The Disease Forecasting Company.

Airfinity tracks, simulates and predicts population level disease outcomes in real time to inform decisions that can increase the global life span.

Independent disease forecasting and health intelligence. Cited over 16,000 times in 2023

Analysis & Insights

H5N1 could combine with seasonal flu to create a more dangerous virus strain
H5N1 could combine with seasonal flu to create a more dangerous virus strain

Read More →


More from Airfinity

Novo’s Wegovy Price Tag for Stroke Prevention Is Higher in US

GSK, Pfizer and Moderna face RSV vaccine sales slump

Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels

The West should be on a war footing for the next pandemic

Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity

View All →

In the News

H5N1 could combine with seasonal flu to create a more dangerous virus strain

The Telegraph | Oct 10, 2024

GSK touts 3-year data on RSV shot Arexvy after CDC's narrower usage recommendation

Fierce Pharma | Oct 8, 2024

GSK ex-vaccines chief says group’s blockbuster flu jab is too expensive

Financial Times | Sep 23, 2024

Novo’s Wegovy Price Tag for Stroke Prevention Is Higher in US

Bloomberg | Sep 20, 2024

View All →

Tech Champions 2023 Healthcare Winner

Tech Startup to Watch 2023

Most Loved Workplaces 2023

A pioneer in predictive health intelligence

Understand

What's happening in a given disease area?

Airfinity is the most comprehensive, single source of intelligence for new developments in your chosen area.

Predict

Identify the true need for a vaccine or a treatment.

Our suite of dynamic predictive indicators help you navigate highly dynamic and uncertain market developments and see the real opportunities.

Act

Maximise impact to save lives

Our analytics and probabilistic tools inform key decisions on resource allocation, investment and procurement decisions to maximise impact of a given drug or vaccine and ultimately improve as many lives as possible.

Analyse, simulate, and predict the changing health landscape

Airfinity develops and deploys dynamic disease forecasting models to support horizon scanning, medical countermeasure impact modelling, clinical trial site optimisation, scenario-based demand intelligence, portfolio optimisation and more.

What our users say?

who

“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”

Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister

hm government

“Airfinity has been instrumental in our country's COVID response.”

Head of UK Government
Vaccine Task Force

ifpma

In a dynamic environment, Airfinity enabled us to remain on track with daily developments to enable more accurate decision-making. Airfinity combines nimbleness of real time data and their group of scientists that can analyse, model and provide strategic analysis for critical decision making.”

Iskra Reic, Executive Vice-President
Astrazeneca

Oxford

“Probably the most expansive, accurate and helpful of the multiple data sets on an international scale”

Sir John Bell ,
University of Oxford